Keybanc Raises Price Target for ELAN, Maintains Overweight Ratin

robot
Abstract generation in progress

Keybanc has increased its price target for Elanco Animal Health (ELAN) from $27.00 to $29.00, reiterating an Overweight rating. This decision follows a series of positive analyst revisions, with Leerink Partners, JP Morgan, and Piper Sandler also raising their price targets and/or upgrading their ratings for ELAN in recent months. Despite the positive analyst sentiment and an average target price implying a slight upside, GuruFocus estimates suggest a significant downside in the stock’s fair value.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin